A Phase 2b, Randomized, Double-Blind, Saline Placebo- and Active-Controlled, Multicenter Study of HTX-011 Via Infiltration for Postoperative Analgesia in Subjects Undergoing Total Knee Arthroplasty
Phase of Trial: Phase II
Latest Information Update: 11 Jan 2018
At a glance
- Drugs Bupivacaine/meloxicam (Primary) ; Bupivacaine
- Indications Postoperative pain
- Focus Pharmacokinetics
- Sponsors Heron Therapeutics
- 05 Jan 2018 Planned number of patients changed from 160 to 260.
- 05 Jan 2018 Planned End Date changed from 1 Apr 2018 to 28 May 2018.
- 05 Jan 2018 Planned primary completion date changed from 1 Mar 2018 to 2 May 2018.